Cryptos: 29,652 Exchanges: 655 Market Cap: $2,680.85B 24h Vol: $45.11B Dominance: BTC 49.8% ETH 17.4% ETH Gas:  5 Gwei
Seclect Currency

Fiat currencies

    Crypto Currencies

      No results for ""

      We couldn't find anything matching your search.Try again with a different term.

      Chintai's Logo

      Chintai - Bridge Round

      Overview Investors Founders Company Profile / Project Introduction

      Overview

      Funding Date

      November 7, 2023

      Financing amount

      --

      Valuation

      --

      Catagory

      Others

      Subcategory

      --

      About Chintai - Bridge Round

      Singapore-based and MAS-licensed blockchain solutions provider Chintai receives bridge financing led by B1. This news comes after Chintai recently launched three pilot projects at an industry event in Singapore, which demonstrated the advantages of tokenization for carbon credits and commercial real estate in Southeast Asia.

      Investors

      InvestorsTypeLocationYear Founded#Portfolio CompaniesEmail AddressSocials
      CorporateCayman Is.--4--

      Founders & Team

      David Packham's Logo

      David Packham

      Company Profile / Project Introduction

      Chintai is a leading one-stop solution for modernizing capital markets, regulated, and licensed by the Monetary Authority of Singapore. The Chintai platform employs blockchain technology to empower traditional finance and innovative companies, enabling them to harness the power of digital assets. The platform provides access to a robust automated compliance engine, powered by Chintai's proprietary Sentinel-AI technology, offering an end-to-end white-labeling solution. Chintai's product suite includes dynamic security token issuance, high-performance secondary trading, and automated compliance infrastructure for regulated digital assets, aiming to bridge the gap between businesses and compliant blockchain technology through its Blockchain Platform-as-a-Service (BPaaS) model.

      View More
      *Fundraising Announcement: Click here